Primarily, GLP-1 RAs help regulate blood glucose levels by stimulating insulin secretion from pancreatic beta cells, whilst decreasing the production of glucagon, a hormone that increases blood glucose
Semaglutide and tirzepatide do not directly cause muscle wasting
BPC-157 and TB-500 are frequently promoted with language that sounds far more definitive than the evidence supports
Your individual body, health, diet, and lifestyle choices will directly affect how soon you see meaningful results
GLP-1 receptor agonists mimic the action of the natural hormone GLP-1, enhancing insulin secretion in response to meals, inhibiting glucagon release, slowing gastric emptying, and promoting satiety
The published Phase 2 obesity trial used 24 weeks as the primary endpoint and 48 weeks as a secondary endpoint